Hepatitis B virus X protein protects hepatoma and hepatic cells from complement‐dependent cytotoxicity by up‐regulation of CD46
暂无分享,去创建一个
Yumei Du | X. You | C. Shan | G. Kong | L. Ye | Xiao-dong Zhang | Shuai Zhang | Wenjing Cui | F. Gao | Xiaona You
[1] Sachiyo Yoshio,et al. [Immunopathogenesis of hepatitis B virus infection]. , 2015, Nihon rinsho. Japanese journal of clinical medicine.
[2] Youliang Wang,et al. Hepatitis B virus X protein modulates oncogene yes‐associated protein by CREB to promote growth of hepatoma cells , 2012, Hepatology.
[3] Yijia Li,et al. Hepatitis B virus/human immunodeficiency virus coinfection: interaction among human immunodeficiency virus infection, chronic hepatitis B virus infection, and host immunity. , 2012, Chinese medical journal.
[4] Yumei Du,et al. Elevation of Highly Up-regulated in Liver Cancer (HULC) by Hepatitis B Virus X Protein Promotes Hepatoma Cell Proliferation via Down-regulating p18* , 2012, The Journal of Biological Chemistry.
[5] D. Hafler,et al. Prostaglandin E2 Affects T Cell Responses through Modulation of CD46 Expression , 2012, The Journal of Immunology.
[6] E. Ratner,et al. Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy , 2012, British Journal of Cancer.
[7] Y. Zhang,et al. HBXIP upregulates CD46, CD55 and CD59 through ERK1/2/NF‐κB signaling to protect breast cancer cells from complement attack , 2012, FEBS letters.
[8] Yumei Du,et al. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. , 2011, Carcinogenesis.
[9] T. Giese,et al. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. , 2010, Current cancer drug targets.
[10] W. Sung,et al. Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3. , 2010, Journal of hepatology.
[11] Jie Zheng,et al. Hepatitis B virus X protein promotes liver cell proliferation via a positive cascade loop involving arachidonic acid metabolism and p-ERK1/2 , 2010, Cell Research.
[12] Qiang Liu,et al. A mutant of hepatitis B virus X protein (HBxDelta127) promotes cell growth through a positive feedback loop involving 5-lipoxygenase and fatty acid synthase. , 2010, Neoplasia.
[13] T. Giese,et al. Primary human hepatocytes are protected against complement by multiple regulators. , 2009, Molecular immunology.
[14] R. Xiang,et al. Gene expression profiles of human liver cells mediated by hepatitis B virus X protein , 2009, Acta Pharmacologica Sinica.
[15] Mu-jun Zhao,et al. Hepatitis B virus X protein sensitizes cells to starvation‐induced autophagy via up‐regulation of beclin 1 expression , 2009, Hepatology.
[16] Hua Yu,et al. Activated Signal Transducers and Activators of Transcription 3 Signaling Induces CD46 Expression and Protects Human Cancer Cells from Complement-Dependent Cytotoxicity , 2007, Molecular Cancer Research.
[17] S. Kaneko,et al. Molecular functions and biological roles of hepatitis B virus x protein , 2006, Cancer science.
[18] F. Chisari,et al. Immunobiology and pathogenesis of viral hepatitis. , 2006, Annual review of pathology.
[19] Lei-Chin Chen,et al. Functional role of NF-IL6β and its sumoylation and acetylation modifications in promoter activation of cyclooxygenase 2 gene , 2006, Nucleic acids research.
[20] T. Wright. Introduction to Chronic Hepatitis B Infection , 2006, The American Journal of Gastroenterology.
[21] S. Meri,et al. Ascitic complement system in ovarian cancer , 2005, British Journal of Cancer.
[22] Enrique Lara-Pezzi,et al. Implicación de la proteína HBx del virus de la hepatitis B en la respuesta inmune y la progresión tumoral , 2003 .
[23] E. Lara-Pezzi,et al. [Role of the hepatitis B virus X protein (HBx) in immune response and tumoral progression]. , 2003, Gastroenterology & hepatology.
[24] Z. Fishelson,et al. Obstacles to cancer immunotherapy: expression of membrane complement regulatory proteins (mCRPs) in tumors. , 2003, Molecular immunology.
[25] P. Martínez,et al. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells. , 2003, Cellular immunology.
[26] A. Levine,et al. Prostaglandin E2 Stimulates Prostatic Intraepithelial Neoplasia Cell Growth through Activation of the Interleukin-6/GP130/STAT-3 Signaling Pathway , 2002 .
[27] A. Levine,et al. Prostaglandin E(2) stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. , 2002, Biochemical and biophysical research communications.
[28] M. Kirschfink. Targeting complement in therapy , 2001, Immunological reviews.
[29] O. Spiller,et al. Cytokine‐mediated up‐regulation of CD55 and CD59 protects human hepatoma cells from complement attack , 2000, Clinical and experimental immunology.
[30] N. Cheung,et al. CD59 expressed on a tumor cell surface modulates decay-accelerating factor expression and enhances tumor growth in a rat model of human neuroblastoma. , 2000, Cancer research.
[31] K. Nouso,et al. Expression of membrane cofactor protein (MCP, CD46) in human liver diseases , 1999, British Journal of Cancer.